JPM26: Eli Lilly enters 2026 with strong momentum given pipeline innovation [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Eli Lilly is shifting to a broader portfolio of medicines across expanded indications, and accelerating its manufacturing capabilities. Additionally, the company is moving past the conventional pharmaceutical model by developing an innovative direct-to-consumer mindset in the form of its LillyDirect Platform to improve access. Eli Lilly has several significant pipeline assets to improve patient outcomes, with six launches and late-stage programs in development, including tirzepatide and orforglipron, indicated for obesity and weight-loss. The company has also launched six additional early-stage clinical programs, and 34 discovery programs with a focus on incretins, amylins, and novel targets. Furthermore, the usage of incretins allows the company to expand into other therapy areas beyond metabolism, such as neuroscience and inflammatory diseases. These pipeline assets are focused on areas such as obesity, diabetes, cardiovascular, renal, and hepatic diseases. Over 75% of these new
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- MoneyShow's Best Investment Ideas For 2026: Part 4 [Seeking Alpha]Seeking Alpha
- Eli Lilly's Most Promising Weight Loss Drug May Come With a Surprising Benefit: Pain Relief [Yahoo! Finance]Yahoo! Finance
- Why Eli Lilly Stock Gained 39.2% In 2025 [Yahoo! Finance]Yahoo! Finance
- Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and Company (NYSE:LLY) had its "outperform" rating reaffirmed by analysts at BMO Capital Markets.MarketBeat
LLY
Earnings
- 10/30/25 - Beat
LLY
Sec Filings
- 1/8/26 - Form 4
- 1/6/26 - Form 3
- 1/6/26 - Form 4
- LLY's page on the SEC website